News
Xerox Highlights COVID-19, Diversity and Climate Change Efforts in 2020 Corporate Social Responsibility Report
Xerox Holdings Corporation has published its 2020 Global Corporate Social Responsibility Report detailing data, accomplishments and goals relating to its work regarding the environment, society and governance.
“While corporate social responsibility isn’t new, this year has crystalized what it really...
News
Moderna CEO Says COVID-19 Vaccine Could Get Emergency Approval in December
As the top three COVID-19 vaccine projects get closer to the finish line, everybody is paying attention to when they might be available. Moderna recently said it expected an EUA submission to the U.S. FDA for its COVID-19 vaccine...
News
Brazil COVID-19 vaccine trial continues despite volunteer death
Clinical trials of the Covid-19 vaccine being developed by Oxford University and AstraZeneca PLC will continue in Brazil despite the death a volunteer, Brazilian health regulator Anvisa said.
Oxford University said it had carried out a careful assessment of the...
Clinical Trials
GSK presents positive clinical data on maternal and older adults RSV candidate vaccines
GSK announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic in Phase I/II clinical studies. The data were presented virtually at the ID Week Congress.
RSV is...
News
AstraZeneca’s Trixeo Aerosphere recommended for approval in the EU by CHMP for the maintenance treatment of COPD
AstraZeneca’s Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) has been recommended for marketing authorisation in the European Union (EU) for maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a...
News
Roche announces full FDA approval for Venclexta combinations for acute myeloid leukaemia
Roche announced that the US FDA has granted full approval of Venclexta® (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly diagnosed acute myeloid leukaemia (AML) in adults 75 years or older,...
News
Vetter continues its long-term investment strategy to sustain future growth
Vetter, a globally leading contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The opening of the new building, known as Ravensburg Vetter Kammerbruehl, represents a clear signal from the family-owned company: stability...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
